Hae
Aineistot 1-1 / 1
PET-measurable reduction in innate immune cell activation in PPMS brain after rituximab treatment
(2021-04-09)
A 48-year-old woman with primary progressive multiple sclerosis (PPMS) was started on rituximab shortly after diagnosis. She underwent serial PET-imaging at an 18-month interval using [11C]PK11195, a first generation 18-kDa ...